Home Tags Neurodegenerative Diseases
Neurodegenerative Diseases Related Content
Dr Yves Joanette, Scientific Director at the CIHR Institute of Aging argues for a balanced approach when it comes to their collaboration-based approach to face the challenge of dementia
Jennifer J. McComas from the University of Minnesota discusses the current evidence for communication intervention for individuals with Rett syndrome
The vital work of the National Institute on Deafness and Other Communication Disorders (NIDCD) and The National Institute of Neurological Disorders and Stroke (NINDS) are explored here by Open Access Government, with a special focus on neurodegenerative disorders.
Tamas Fulop from Université de Sherbrooke’s Research Center on Aging, explains precisely why infections may be the new paradigm explaining the pathogenesis of Alzheimer’s disease (AD)
NIH-funded study closes in on personalised drug testing for neurological disorders
Scientists from the National Institutes of Health (NIH) compared the genetic clocks of normal and mutant flies to understand the link between neurodegenerative disorders such as Alzheimer’s disease and the ageing process
Svein Olaf Olsen and Maiken Arnesen from the European Huntington Association reveal their thoughts on a recent and significant breakthrough concerning Huntington’s Disease (HD) research The 11th December 2017 will probably go into history along with the discovery of the Huntington gene in 1993. On this date, IONIS Pharmaceuticals announced...
UCB's Duncan McHale outlines why reclassification might be a good idea to boost drug development for neurodegenerative diseases like Alzheimer's and Parkinson's Neurodegenerative diseases are a growing global challenge, as medical advances ensure more individuals live longer. By 2020 there will be more than 40 million people in the world...
The European Parkinson’s Disease Association (EPDA) provide an update about the positive progress being made for people with Parkinson’s My PD Journey is a multi-stakeholder European coalition led by the European Parkinson’s Disease Association (EPDA) and it is a positive development in terms of the positive progress being made for...
Emory University’s Stuart Zola considers the case for classifying Alzheimer’s disease as a spectrum disorder and the promise of precision medicine as an intervention.
The defect that causes Huntington's disease has been corrected in patients for the first time with an experimental drug Experts believe that the new experimental drug, which is injected into spinal fluid, could be the biggest breakthrough in neurodegenerative diseases for 50 years. The unstoppable death of brain cells in Huntington's gradually causes...
Prof. Dr Axel Rominger from the Ludwig-Maximilian-University of Munich on how neurodegenerative diseases can be studied through PET imaging
A paradigm shift is needed if researchers are to find a successful for treatment for Alzheimer’s disease, argues Ai-Ling Lin of the Lin Brain Lab.
Prof. David Dexter, deputy director of research at Parkinson’s UK shares his thoughts on the symptoms of Parkinson’s and the chances of finding a cure
The Alzheimer's Society in the UK provides a fascinating glimpse into the most dementia as a progressive condition and its common forms
Naoko Tanese from New York University explores how monitoring gene expression can be used to treat neurodegenerative diseases such as Huntington's
A man in a vegetative state in France has regained a degree of consciousness after experimental therapy of placing a nerve stimulator on his chest After being in a vegetative state for 15 years, the unnamed 35-year-old patient responded to nerve stimulator therapy and within a month was able to...
Ai-Ling Lin PhD, of The Lin Brain Lab talks about the reversal of cognitive decline in Alzheimer’s disease with comprehensive and personalised nutrition Alzheimer’s disease (AD) represents the most common cause of dementia, accounting for 60% to 80% of all dementia cases. There are currently only a few interventions that...
The World Health Organization, says recognising dementia as a public health priority is key to addressing the condition globally
Writing on behalf of the Chartered Society of Physiotherapy, Dr. Bhanu Ramaswamy highlights how physiotherapy can help manage the symptoms of Parkinson’s